SBIR/STTR Research Award
Cancer Trials CareLink for Patient Self Reports
Award amount
$99,267Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CLINICIAN SUPPORT TECHNOLOGY, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): We propose Cancer Trials CareLink, an
Internet-based system to gather research-quality, self-reported quality of
life, supportive care, and satisfaction outcomes directly from patients in
their homes. Patient self-reported data are of paramount importance for
comparing treatments in clinical trials and in daily cancer care.
Internet-based data collection offers significant advantages for improving the
quality, timeliness, and cost of data capture, compared with alternative
methods. Cancer Trials CareLink will link patients directly to their cancer
trials site through a dedicated, secure Internet channel enabling two-way,
multi-media communication between patients and their providers. Patients will
have broad access to needed content and functionality to help them in their
daily cancer care. Using a patient-centric, care contextual portal environment
for data gathering, patients will be motivated, empowered, and supported so
they may more easily and willingly provide research-quality self-reports for
clinical trials. Benefits will include improved satisfaction with trials
participation, easier self reporting, improved compliance with trial protocols,
and lower data collection costs. Our Phase I research will demonstrate
feasibility by having a working prototype that patients can and will use to
provide self-reported data from their homes to their clinicians/researchers at
a local trial site.
PROPOSED COMMERCIAL APPLICATION:
Cancer Trials CareLink is needed by and will be of value to cancer trial sites including hospitals
university research centers and cancer centers. These institutions are investing in more
efficient means to collect and manage data and to maintain communication with their patient
populations. Pharmaceutical companies and contract research organizations can use Cancer
Trials CareLink to enhance clinical and outcomes data collection from patients in trials and to
monitor drug safety during trials and over time.
Technology keywords
Not reported